IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sphere of biopharmaceuticals, offering promising advancements across a variety of medical and industrial apps. With its structural similarity to Obviously derived human serum albumin, OsrHSA supplies a safer, additional reputable alternate for therapeutic use, specifi